Pharma Journalist -

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, announced it received…
Read More...

The European Commission (EC) has granted marketing authorization for Jardiance (empagliflozin) as a treatment for adults with symptomatic chronic heart failure, Boehringer Ingelheim and…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of a first generic version of Revlimid (lenalidomide capsules), in 5mg, 10mg, 15mg,…
Read More...

UCB announced the successful completion of the previously announced transaction to acquire Zogenix for US$ 26.00 per share plus a milestone-based contingent value right for a potential…
Read More...

SMi Reports: Chemaxon release an interview prior to joining the SMi’s 3rd Annual AI in Drug Discovery Conference on 14-15 March 2022 in London as a key sponsor. In less than 2 weeks…
Read More...

Adagene Inc. announced a collaboration and exclusive license agreement with Sanofi to generate masked monoclonal and bispecific antibodies for development and commercialization by…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo(nivolumab) 360 mg (injection for intravenous use) in combination with platinum-doublet…
Read More...

The countdown has begun for the most prestigious pharmaceutical conclave that is about to kick off in Hyderabad on April 7, 2022.  The last few seats to this dynamic conference…
Read More...

Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, announced collaborations with Bruker Corporation, a company with…
Read More...

Helsinn Group (Helsinn), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and…
Read More...